BTK and lymphoma: This metabolic impairment has significant translational implications because imaging-based detection of decreases in tumor lactate (typically reflecting glycolysis) and alanine (an indicator of amino-acid-dependent oxidative metabolism) may serve as an early, reliable, and sensitive biomarker of the BTK inhibition response in patients with lymphoma.